1.代表论文（#为并列第一作者，*为通讯作者）：
① Xin Yu#, Yao Lin#, Hui Chen#, Min-Juan Wu, Li-Na Huang, Yi-Yan Song , Bin-Bin Gu , Zhi-Jian Ye , Ping Xu* , Jian-Ping Zhang*, Jun-Chi Xu*. Distribution and clinical significance of circulating CD8 + CD28 - regulatory T cells in the peripheral blood of patients with pulmonary tuberculosis. BMC Pulm Med. 2022 Jul 30;22(1):291.
② Rui Qiang, XinZhi Liu, Jun-chi Xu*. The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis. Front Immunol. 2022 Jul 14;13:935160.
③ Xin Yu#; Jun?Chi Xu#*; Yi?Yan Song#; Hui Chen; Cui?Lin Shi; Pei?Jun Tang; Tao Tao*; Ye?Han Zhu*;The exhaustion of lymphocytes is the main factor that decreases the sensitivity of QFT-GIT detection in silicosis, Bmc Immunology, 2022, 23(62).
④ Cui-lin Shi#, Jian-ping Zhang#, Ping Xu#, Jin Li, Jie Shen, Mei-ying Wu, Zhi-jian Ye, Xin Yu, Hua-feng Song, Hui Chen, Jun-chi Xu*, Yu Pang* and Jian-an Huang*. Upregulation of PD-1 expression on circulating CD8+ but not CD4+ T cells is associated with tuberculosis infection in health care workers. BMC Immunology. 2021; 22: 39.
⑤ Hui Chen#, ChuanLu Ren#, HuaFeng Song#, Li-Ling Ma#, Su-Fang Chen, Min-Juan Wu, HuiDan Zhang*, Jun-Chi Xu*, Ping Xu*. Temporal and spatial characterization of negative regulatory T cells in HIV-infected AIDS patients raises new diagnostic markers and therapeutic strategies. Journal of Clinical Laboratory Analysis. 2021; 00: e23831.
⑥ Yi Wang#, Lin Yao#, Jian-Ping Zhang#, Pei-Jun Tang, Zhi-Jian Ye, Xing-Hua Shen, Jun-Chi Xu*, Mei-Ying Wu*, Xin Yu*. Clinical characteristics and laboratory indicator analysis of 69 COVID-19 pneumonia patients in Suzhou, China. BMC infectious diseases. 2020;20:747.
⑦ Jun-Chi Xu#, Fei Gao#, Yi-An Liu#, Xiao-Long Zhang, Hui Chen, Xiao-Yan Zhu, Hua-Feng Song, Feng Qian, Ming Li, Chen Yang*,Chuan-Wu Zhu*, Ping Xu*. Myeloid cell-like transcript 2 is related to liver inflammation and the pathogenesis of hepatitis B via the involvement of CD8+T cell activation. Clinical and Experimental Medicine. 2019;19(1):93-104.
⑧ Cui-Lin Shi#, Jun-Chi Xu#, Hui Chen, Zhi-Jian Ye, Xin-Nian Chen, Pei-Jun Tang, Li-Ling Ma, Zai-Xiang Tang, Mei-Ying Wu*, Ping Xu*. Risk factors of latent tuberculosis infection and immune function in health care workers in Suzhou, China. Journal of Thoracic Disease. 2018;10(12):6742-6752.
⑨ Fei Gao#, Jun-Chi Xu#, Li Zhu, Hui Chen, Xiao-Yan Zhu, Xin-Ran You, Shu-Xiang Li, Chen-Lu Zhu, Chen Yang*, Chuan-Wu Zhu*, and Ping Xu*. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection. Viral Immunology. 2018;31(10): doi: 10.1089/vim.2018.0102.
⑩ Jun-Chi Xu#, Ze-Yi Li#, Xin-Nian Chen, Cui-Lin Shi, Mei-Ying Wu, Hui Chen, Xiao-Yan Zhu, Hua-Feng Song, Min-Juan Wu, Ping Xu*. More significance of TB-IGRA except for the diagnose of tuberculosis. Journal of Clinical Laboratory Analysis. 2018, 32:e22183.
2.主要承担的科研项目：
①苏州市卫生健康委员会，苏州市“科教兴卫”临床重点病种诊疗技术项目，LCZX202116，基于临床队列建立结核病精准免疫干预策略及其转化应用，2022/1-2024/12，30万元，在研，主持。
②苏州市科技局，苏州市医疗卫生科技创新（关键技术攻关），SKY2021061，以负性共刺激分子LAG3位靶点的耐多药结核病精准免疫干预策略的建立，2021/07-2024/06，10万元，在研，主持。
③苏州市科技局，苏州市民生科技（基础研究），SYS2020192，以IL-33为靶点的慢加急肝衰早期预警模型和靶向治疗方案的建立，2020/07-2023/06，5万元，在研，主持。
④国家自然基金委，国家自然基金青年科学基金项目，81900577，IL-33/ST2信号通路调控T细胞肝内浸润在慢加急性肝衰竭病程进展中的作用和机制研究，2020/01-2022/12，20万元，在研，主持。
3.获奖情况：
①徐俊驰(3/10), 结核抗原特意性T细胞在肺结核诊疗中的应用，中国防痨协会科学技术奖，三等奖，2021。（胥萍，吴妹英，徐俊驰，宋华峰，陈慧，顾德林，龚玉华，赵静，张建平，唐佩军，吴敏娟，陈苏芳，薛婧，时翠林）。
②徐俊驰(2/9), 肺结核患者外周血T细胞与实验室诊断有效性分析及免疫治疗肺结核的应用，苏州市人民政府，苏州市科学技术进步奖，三等奖，2017(胥萍, 徐俊驰, 吴妹英, 赵静, 宋华峰, 唐佩军, 陈慧, 吴敏娟, 王凤平)。
4.学术任职：
① 江苏省医学会感染病分会青年委员
② 江苏省医学会结核病专业委员会诊断学组秘书
③ 苏州市医学会结核病分会委员
④ 苏州市医学会科研管理委员会青年委员
5.杂志编委：
Infectious Diseases of Poverty杂志审稿人